Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Icu Medical (ICUI) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Icu Medical (ICUI) over the last 17 years, with Q3 2025 value amounting to $336.1 million.

  • Icu Medical's Cost of Revenue fell 1253.52% to $336.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year decrease of 617.04%. This contributed to the annual value of $1.6 billion for FY2024, which is 250.2% up from last year.
  • Per Icu Medical's latest filing, its Cost of Revenue stood at $336.1 million for Q3 2025, which was down 1253.52% from $340.8 million recorded in Q2 2025.
  • In the past 5 years, Icu Medical's Cost of Revenue registered a high of $416.3 million during Q4 2023, and its lowest value of $198.1 million during Q2 2021.
  • For the 5-year period, Icu Medical's Cost of Revenue averaged around $345.0 million, with its median value being $376.6 million (2023).
  • Its Cost of Revenue has fluctuated over the past 5 years, first skyrocketed by 9854.4% in 2022, then tumbled by 1253.52% in 2025.
  • Over the past 5 years, Icu Medical's Cost of Revenue (Quarter) stood at $213.0 million in 2021, then skyrocketed by 89.2% to $403.1 million in 2022, then rose by 3.28% to $416.3 million in 2023, then dropped by 3.3% to $402.5 million in 2024, then fell by 16.5% to $336.1 million in 2025.
  • Its last three reported values are $336.1 million in Q3 2025, $340.8 million for Q2 2025, and $394.6 million during Q1 2025.